To date, aberrant upregulation of SCUBE3 expression has been associated with unfavorable outcomes in various tumors, including NSCLC [181], breast cancer [181], metastatic melanoma [175], and osteosarcoma [181]. Here, SCUBE3 is linked to non-small cell lung carcinoma.